Table 7.
Adverse events related to patient controlled analgesia#.
| Adverse events | CFNB (n = 127) | PCIA (n = 123) | P value |
|---|---|---|---|
| PCA period | |||
| Incomplete analgesia | |||
| In motion | 9 (7.08) | 21 (17.07) | 0.015∗ |
| At rest | 0 (0) | 0 (0) | — |
| Oversedation | 2 (1.57) | 5 (4.06) | 0.275 |
| Nausea and vomiting | 3 (2.36) | 4 (3.25) | 0.719 |
| Respiratory depression | 0 (0) | 2 (1.62) | 0.149 |
| Muscle weakness | 4 (3.14) | 1 (0.81) | 0.370 |
| Catheter thrombosis | 0 (0) | 0 (0) | — |
| Catheter dropout | 0 (0) | 0 (0) | — |
| Local hematoma | 0 (0) | 0 (0) | — |
| Local infection | 0 (0) | 0 (0) | — |
| Non-PCA period | |||
| Incomplete analgesia | 15 (11.8) | 25 (20.3) | 0.066 |
| Oversedation | 0 (0) | 0 (0) | — |
| Nausea and vomiting | 1 (0.78) | 0 (0) | 1.000 |
| Respiratory depression | 0 (0) | 0 (0) | — |
#For events less than 5 in both groups, Fisher's exact test was used; the rest were compared using chi-square test, *Pvalue <0.05.